Doctronic navigation menu Log In
Doctronic navigation menu

Contents
  • Benefits of Hormone Therapy
  • Risks to Consider
  • Understanding the Timing

Hormone Therapy: Friend or Foe for Menopausal Symptoms?

Hormone Therapy: Friend or Foe for Menopausal Symptoms?

The Big Question

Hormone therapy can help with menopause symptoms, but is it safe? This article uncovers what you need to know.
Contents
  • Benefits of Hormone Therapy
  • Risks to Consider
  • Understanding the Timing

Benefits of Hormone Therapy

MHT is highly effective in relieving menopausal symptoms like hot flashes and night sweats. Estrogen, the primary component, helps improve quality of life during menopause. However, it's important to weigh these benefits against potential risks before starting therapy.

Risks to Consider

While MHT can ease menopause symptoms, it may increase the risk of certain conditions such as breast cancer, stroke, and blood clots. The type of hormones, age at therapy initiation, and individual health factors all contribute to these risks. Consulting with a healthcare provider can help determine the best course of action.
Menopausal Hormone Therapy is used to relieve symptoms of menopause such as hot flashes and night sweats. It involves the administration of estrogen, often combined with progestin.

Understanding the Timing

The timing of starting MHT plays a significant role in its safety profile. Beginning therapy close to the onset of menopause may offer more benefits and fewer risks compared to starting it later in life. This concept, known as the 'timing hypothesis,' is essential for making informed decisions about MHT.

FAQs

Can MHT help with hot flashes?

Yes, MHT is effective in reducing hot flashes.

Does MHT increase cancer risk?

MHT may increase breast cancer risk.

What is the timing hypothesis?

It suggests starting MHT near menopause may reduce risks.

Weighing the Options

Balancing benefits and risks is key to deciding on hormone therapy.
Discuss with Doctronic how MHT might be right for your menopause symptoms.
Additional References
  1. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349:523.
  2. Rossouw JE, Cushman M, Greenland P, et al. Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy. Arch Intern Med 2008; 168:2245.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.